Argonaute
Cardiff, GB · 1 known investors
Argonaute RNA develops siRNA-based (RNA interference) therapeutics, with a pipeline focused on cardiovascular disease, combining oligonucleotide chemistry and drug development expertise. The UK biotech takes early-stage academic ideas through preclinical and clinical development.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Argonaute do?
- Argonaute RNA develops siRNA-based (RNA interference) therapeutics, with a pipeline focused on cardiovascular disease, combining oligonucleotide chemistry and drug development expertise. The UK biotech takes early-stage academic ideas through preclinical and clinical development.
- Who founded Argonaute?
- Argonaute was founded by Anthony Parker, Richard Tompkins.
- Who are Argonaute's investors?
- Argonaute's investors include Oxford Investment Opportunity Network (OION).
- Where is Argonaute headquartered?
- Argonaute is headquartered in Cardiff, GB.